login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ARMATA PHARMACEUTICALS INC (ARMP) Stock News
NYSEARCA:ARMP -
US04216R1023
-
Common Stock
2.9487
USD
+0.09 (+3.1%)
Last: 9/9/2025, 8:04:00 PM
2.801
USD
-0.15 (-5.01%)
After Hours:
9/9/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARMP Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Benzinga
- Mentions:
EDAP
ARTL
UPC
BDSX
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
25 days ago - By: Zacks Investment Research
All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
25 days ago - By: Zacks Investment Research
- Mentions:
AVDL
Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
a month ago - By: The Motley Fool
Armata Posts 59 Percent Q2 Revenue Jump
a month ago - By: Zacks Investment Research
- Mentions:
IVVD
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
HALO
AMRN
ARMP Soars 72% in a Month Following Infectious Disease Study Success
4 months ago - By: Zacks Investment Research
- Mentions:
COLM
EFSI
New Strong Sell Stocks for May 8th
4 months ago - By: Zacks Investment Research
- Mentions:
CCS
CABO
New Strong Sell Stocks for April 28th
3 years ago - By: Benzinga
Investors Cheer Armata Pharma's Encouraging Data From Lung Infection Candidate
4 months ago - By: Zacks Investment Research
- Mentions:
DTIL
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
ADCT
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
SGMO
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates
a year ago - By: InvestorPlace
ARMP Stock Earnings: Armata Pharmaceuticals Beats EPS for Q2 2024
a year ago - By: InvestorPlace
- Mentions:
SILV
GSL
INVA
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge
a year ago - By: InvestorPlace
ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
a year ago - By: InvestorPlace
ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
2 years ago - By: Seeking Alpha
- Mentions:
INVA
Armata Pharmaceuticals gets $25M in financing and new executive chief (NYSE:ARMP)
2 years ago - By: InvestorPlace
- Mentions:
ICU
IFBD
CWD
NBY
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Please enable JavaScript to continue using this application.